UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 2,925 Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) by 7.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,324 shares of the company’s stock after […]
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) by 7.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,324 shares of the company’s stock after […]
